Jefferies Financial Group’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$20.8M	Buy	1,388,854 +140,000	+11%	+$2.1M	0.17%	63
2025 Q1	$20.2M	Buy	1,248,854 +31,900	+3%	+$515K	0.18%	50
2024 Q4	$28.3M	Buy	1,216,954 +762,147	+168%	+$17.7M	0.17%	56
2024 Q3	$13.4M	Buy	454,807 +357,234	+366%	+$10.5M	0.1%	76
2024 Q2	$2.29M	Buy	+97,573	New	+$2.29M	0.02%	369